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ABSTRACT Mutations in the human TPM3 gene encoding -tropomyosin (-tropomyosin-slow) expressed in slow skeletal
muscle fibers cause nemaline myopathy. Nemaline myopathy is a rare, clinically heterogeneous congenital skeletal muscle
disease with associated muscle weakness, characterized by the presence of nemaline rods in muscle fibers. In one missense
mutation the codon corresponding to Met-8, a highly conserved residue, is changed to Arg. Here, a rat fast -tropomyosin
cDNA with the Met8Arg mutation was expressed in Escherichia coli to investigate the effect of the mutation on in vitro
function. The Met8Arg mutation reduces tropomyosin affinity for regulated actin 30- to 100-fold. Ca2-sensitive regulatory
function is retained, although activation of the actomyosin S1 ATPase in the presence of Ca2 is reduced. The poor activation
may reflect weakened actin affinity or reduced effectiveness in switching the thin filament to the open, force-producing state.
The presence of the Met8Arg mutation severely, but locally, destabilizes the tropomyosin coiled coil in a model peptide, and
would be expected to impair end-to-end association between TMs on the thin filament. In muscle, the mutation may alter thin
filament assembly consequent to lower actin affinity and altered binding of the N-terminus to tropomodulin at the pointed end
of the filament. The mutation may also reduce force generation during activation.
INTRODUCTION
Nemaline myopathy is a rare, clinically heterogeneous con-
genital skeletal muscle disease with associated muscle
weakness, characterized by the presence of nemaline rods in
skeletal muscle fibers, and within the nucleus in severe
cases (Shy et al., 1963; reviewed in North et al., 1997;
Laing, 1999). Nemaline rods originate at the Z-line and are
formed of actin filaments and -actinin, which presumably
cross-links the filaments (Yamaguchi et al., 1978, 1982;
Jockusch et al., 1980; Morris et al., 1990; Wallgren-Petters-
son et al., 1995) implying that the mutations may affect thin
filament assembly or stability. Congenital nemaline myop-
athy has, so far, been mapped to three genetic loci: the
NEM1 locus is the TPM3 gene that encodes -TM (-TM-
slow, Laing et al., 1995), the NEM2 locus is the nebulin
gene (Pelin et al., 1999), and ACTA1 is the skeletal muscle
-actin gene (Nowak et al., 1999). In the present study we
have investigated the effect of a missense mutation on
tropomyosin (TM) function.
Tropomyosin is a coiled coil protein that binds head-to-
tail along the length of actin filaments. The striated muscle
thin filament contains actin, TM, and troponin (Tn), and is
cooperatively activated by two ligands: Ca2, which binds
to TnC, and myosin, which binds to and whose ATPase is
activated by actin. The cooperativity depends on TM (re-
viewed in Lehrer, 1994; Tobacman, 1996). Tropomyosins
form a highly conserved family of proteins (reviewed in
Pittenger et al., 1994). Three forms are expressed in human
striated muscles. The most abundant forms are -TM, a
product of the TPM1 gene; -TM (TPM2 gene), and -TM
(TPM3 gene, also referred to as the nmTM gene). -TM and
-TM have similar sequences, being 92.6% identical in
humans (Reinach and MacLeod, 1986; Clayton et al., 1988;
MacLeod and Gooding, 1988). The isoforms are expressed
in developmental and fiber-specific patterns (Salviati et al.,
1984; reviewed in Schiaffino and Reggiani, 1996). For
example, type 2, fast fibers (as well as cardiac muscles) may
have -TM or -TM, whereas type 1, slow fibers contain
-TM, and the other two isoforms. For this reason, -TM
is sometimes referred to as -TM-fast, and -TM as
-TM-slow.
Three independent mutations have been identified in the
TPM3 gene that cause nemaline myopathy: a missense
mutation, Met9Arg (Laing et al., 1995), recently referred to
as Met8Arg (Laing, 1999), is dominant; a nonsense muta-
tion at codon 31, resulting in premature termination, is
recessive (Tan et al., 1999); and a missense mutation of the
termination codon 285 to Ser, resulting in 57 additional
amino acids encoded at the C-terminus (A. Beggs, personal
communication), causes recessive but severe disease. The
two mutations that would result in expressed protein are at
the ends of TM, the site of head-to-tail association of TM
molecules along the actin filament. It is well-established
that the ends of TM are critical determinants of actin affinity
and cooperative TM function (e.g., Lehrer et al., 1997;
Moraczewska et al., 1999). The N-terminal sequence of
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284-residue TMs is highly conserved throughout phylog-
eny, and Met-8 is invariant.
In the present work we have introduced the Met8Arg
mutation into a rat -TM-fast cDNA, and studied the effect
of the mutation on the in vitro function of recombinant
protein expressed in Escherichia coli. Actin affinity is
greatly reduced. Ca2-sensitive regulatory function is nor-
mal, although activation of the actomyosin S1 ATPase in
the presence of Ca2 is reduced. The presence of the
Met8Arg mutation severely, but locally, destabilizes the TM
coiled coil in a model peptide. We suggest that the mutation
would severely alter end-to-end association of TM mole-
cules on the thin filament. The functional consequence of
the mutation could be lower actin affinity and thin filament
assembly, stability, and reduced force generation during
activation.
MATERIALS AND METHODS
Nemaline myopathy mutant construction
General DNA recombination methods were carried out as described by
Sambrook et al. (1989) or as recommended by the supplier. Plasmid DNA
was purified using Quiagen DNA preparation kits (Chatsworth, CA).
The nemaline myopathy mutation was introduced using oligonucleo-
tide-directed mutagenesis into rat striated muscle -TM cDNA (gift of Dr.
B. Nadal-Ginard; Ruiz-Opazo and Nadal-Ginard, 1987) that was previ-
ously cloned into pET11d (Studier et al., 1990; Hammell and Hitchcock-
DeGregori, 1996). Two oligonucleotide primers were synthesized on an
Applied Biosystems DNA synthesizer, purified using a NENSORB car-
tridge (UMDNJ-DNA Synthesis and Sequencing Facility at Robert Wood
Johnson Medical School, Piscataway, NJ) and phosphorylated enzymati-
cally using phage T4 polynucleotide kinase. One oligonucleotide (a 25-
mer) was complementary to pET11d plasmid and cDNA coding sequence
5 to the Met8Arg mutation: 3-GTGGTACCTGCGGTAGTTCTTCTTC-
5. The second oligonucleotide (a 27-mer) was the coding sequence starting
at codon 8 which was changed from ATG (Met) to CGC (Arg): 5-
CGCCAGATGCTGAAGCTCGACAAAGAG-3. The synthesis was car-
ried out using a Stratagene ExSite PCR-based site-directed mutagenesis kit
(La Jolla, CA) with Taq DNA polymerase. The PCR product was ligated
using T4 ligase and used for transformation of Stratagene Epicurean Coli
XL1-Blue Supercompetent Cells (La Jolla, CA). The transformed cells
were plated for colony isolation. Single colonies were reisolated and then
used for DNA preparation. The mutation was confirmed by sequencing of
the entire cDNA on an ABI Perkin-Elmer-Cetus 277 PRISM automatic
DNA sequencer by the UMDNJ-DNA Synthesis and Sequencing Facility
at Robert Wood Johnson Medical School, Piscataway, NJ.
Protein expression and purification
Recombinant TM was expressed in E. coli BL21(DE3)pLysS expression
cells (Studier et al., 1990) and purified as previously described (Hitchcock-
DeGregori and Heald, 1987; Hammell and Hitchcock-DeGregori, 1996)
except the (NH4)2SO4 fractionation was 35–70% saturation instead of
35–60%. The N-terminal Met is unacetylated when expressed in E. coli.
The mutation was further confirmed by sequencing of the N-terminal 12
amino acids on Procise cLC amino acid sequencer at the W. M. Keck
Foundation Biotechnology Resource Laboratory (Yale University, New
Haven, CT).
Actin was isolated from White Leghorn chicken pectoral muscle ace-
tone powder (Hitchcock-DeGregori et al., 1982), except that actin was
polymerized by addition of KCl and MgCl2 to 20 mM and 0.7 mM,
respectively, and incubated at 37°C for 10 min before polymerization at
room temperature. Myosin S1 was prepared by papain digestion of chicken
pectoral myosin (Margossian and Lowey, 1982). Troponin was purified
from chicken pectoral muscle (gift of Dr. J. Fagan, Rutgers University,
New Brunswick, NJ) according to the method of Potter (1982), with
modifications described in Moraczewska et al. (1999).
The concentrations of actin, myosin S1, and Tn were spectrophotometri-
cally determined using the extinction coefficients at 280 (0.1%) of 1.1,
0.83, and 0.45, respectively. Concentrations of recombinant TM were
determined by differential absorption spectra of tyrosine as previously
described (Edelhoch, 1967; Lehrer, 1975; Hammell and Hitchcock-
DeGregori, 1996).
Actin binding assays
TM binding to F-actin was measured using a cosedimentation assay as
previously described (Heald and Hitchcock-DeGregori, 1988) with modi-
fications (Urbancikova and Hitchcock-DeGregori, 1994). The amount of
bound and free TM in the pellets and supernatants, respectively, were
quantified by densitometry of SDS-polyacrylamide gels (Laemmli, 1970)
using Molecular Dynamics Model 300A computing densitometer (Sunny-
vale, CA). The apparent Ka of TM for F-actin and Hill coefficient (
H)
were determined by fitting the experimental data to the equation using
SigmaPlot (Jandel Scientific, San Rafael, CA):
v nTMnHKapp
nH /1 TMnHKapp
nH  (1)
where v fraction maximal TM binding to actin, n maximal TM bound,
[TM] [TM]free. The TM/actin ratio was normalized to 1.0 by dividing the
TM/actin ratio obtained from densitometry by the TM/actin maximal ratio
(n) from each experiment calculated using Eq. 1. The TM/actin density
ratio at saturation was the same for all TM isoforms, indicating that the
same mass of TM binds to actin independent of the length of the TM. We
have previously shown that the observed density ratio at saturation reflects
stoichiometric binding of TM to actin (Cho and Hitchcock-DeGregori,
1991). We have normalized the data because the intensity of the staining is
somewhat variable from experiment to experiment.
Myosin S1-induced tropomyosin binding to actin
Actin (3 M) and TM (1 M) in 30 mM NaCl, 0.5 mM MgCl2, 1 mM
DTT, 10 mM imidazole, pH 7.0, were mixed with myosin S1 (0–4.2 M).
The mixture was incubated at room temperature for 30 min to ensure
hydrolysis of residual ATP from F-actin and then centrifuged in a TLA-100
rotor for 25 min, at 60,000 rpm, 20°C, in a Beckman TL-100 ultracentri-
fuge (Fullerton, CA). The pellets were washed with assay buffer and then
solubilized in actin extraction buffer (5 mM imidazole, pH 7.0, 0.5 mM
DTT, 0.1 mM CaCl2, 0.1 mM ATP) by sonication in an ultrasonic cleaner.
Pellets were electrophoresed on 12% SDS-PAGE gels (Laemmli, 1970).
Proteins were visualized with Coomassie brilliant blue. The composition of
proteins sedimented in pellets was analyzed by densitometry. The results
were plotted as the TM/actin and S1/actin ratio obtained from intensities of
protein bands on the gel versus the initial S1/actin molar ratio. The data
were fit to Eq. 2, modified from Eq. 1, using SigmaPlot (Jandel Scientific,
San Rafael, CA):
v nXnHKnH/1 XnHKnH C (2)
where v  TM/actin ratio; [X]  S1/actin molar ratio, and C  TM/actin
ratio without S1. The S1/actin ratio necessary for half-maximal saturation
of actin with TM  1/K. The maximal TM/actin ratio was the same for
both tropomyosins, indicative of complete saturation.
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Acto-myosin S1 MgATPase assay
The acto-S1 ATPase activity was measured as a function of TM concen-
tration using 5 M actin, 1 M myosin S1, 1 M Tn, and 0 to 1 M TM
in 40 mM NaCl, 5 mMMgCl2, 5 mM imidazole, pH 7.0, 0.5 mM DTT, and
either 0.1 mM CaCl2 or 0.2 mM EGTA. Assays were carried out in 96-well
microtiter plates at 28°C in a thermoequilibrated Molecular Devices Ther-
moMax microtiter reader (Menlo Park, CA). The reaction was initiated by
adding MgATP to final concentration 2 mM and terminated after 15 min by
adding SDS and EDTA to final concentration 3.3% and 30 mM, respec-
tively. The amount of inorganic phosphate released was determined colo-
rimetically (White, 1982). The plates were read in a Molecular Devices
ThermoMax plate reader with a 650 nm filter (Menlo Park, CA). Specific
activity was expressed as nanomoles Pi/s/nmol S1.
The Ca2-dependence of the acto-myosin S1 ATPase was carried out
under the same conditions except that wild-type TM  0.8 M, Met8Arg
TM  5 M, and in the presence of 0.45 mM CaEGTA. The ratio of
Ca2/EGTA was varied to determine the desired free Ca2, as previously
described (Mukherjea et al., 1999). The data were fit to Eq. 2, where v 
specific activity, n  maximal specific activity, [X]  [Ca2], Kapp 
apparent Ka of Ca
2 for activation, and C  constant for activity at
[Ca2]  0.
Peptide synthesis and circular
dichroism measurements
TMZip was synthesized as previously described (Greenfield et al., 1998).
Met8Arg TMZip was synthesized on a Rainin Symphony instrument
(HHMI Biopolymer/Keck Foundation Biotechnology Resource Labora-
tory, Yale University School of Medicine). The N-terminal methionine was
acetylated. The molecular weight, 3913.6, determined by MALDI mass
spectrometry, was within the limits of accuracy of the technique of the
weight of expected from the amino acid sequence, 3912.0.
CD measurements were made and analyzed using an Aviv model 62 DS
spectropolarimeter (Lakeview, NJ) as previously described (Greenfield et
al., 1998).
RESULTS AND DISCUSSION
To gain an understanding of how the nemaline myopathy-
causing mutation of Met9Arg in -TM encoded by TPM3
causes disease, recently referred to as Met8Arg in Laing
(1999), we investigated the effect of the mutation on TM
structure and function. In -TMMet-9 corresponds to Met-8
in other TMs. It is conserved throughout phylogeny in
284-residue TMs or their equivalents. The first nine residues
of TM have been proposed to overlap with the C-terminal
nine residues of the adjacent TM on the actin filament. The
N-terminal overlap region forms a coiled coil structure in a
model peptide (Greenfield et al., 1998) although the struc-
ture of the complex is unresolved in the TM x-ray structure
(Whitby and Phillips, 2000). Met-8 is at an a position at the
interface between the two chains of the coiled coil (Fig. 1).
Since the striated muscle -TM (-TM-fast) has been
extensively analyzed, we introduced the Met8Arg mutation
into the rat striated -TM cDNA. There are 19 amino acid
differences between rat striated -TM and human striated
-TM, spaced throughout the sequence. In the overlap re-
gion, residue 2 is Asp in rat -TM and Glu in human -TM,
as it is in some vertebrate -TMs. The sequences are then
identical until residue 28 (D28E, K29Q, A31Q, D34E). The
mutation was initially referred to as Met9Arg because of an
additional Met at the N-terminus in the original cDNA
sequence (MacLeod and Gooding, 1988; Laing, 1999).
More recently, the mutation has been called Met8Arg (La-
ing, 1999) because the first Met is presumably removed
after translation. Rat Met8Arg TM expressed well in E. coli;
the N-Met is unacetylated.
Actin affinity
A universal TM function is the ability to bind cooperatively
to F-actin. In skeletal muscle, TM and Tn assemble with
F-actin to form regulated actin filaments. Fig. 2 A shows
that Met8Arg TM bound to actin with Tn (Ca2), but the
affinity was at least 30-fold weaker than wild type, at the
limit of sensitivity for our assay. With actin alone, binding
of Met8Arg TM, like wild-type TM, was too weak to
measure, a consequence of the unacetylated N-terminal Met
(Heald and Hitchcock-DeGregori, 1988; Urbancikova and
Hitchcock-DeGregori, 1994). In the absence of Ca2, the
actin binding was stronger and cooperative, but Met8Arg
TM still bound with 	100-fold weaker affinity than wild-
type TM (Fig. 2 B). Clearly, the single amino acid change
dramatically affects the assembly of Met8Arg TM onto
regulated actin filaments.
Myosin S1-induced binding of Met8Arg
tropomyosin to actin
Myosin S1 increases the affinity of TM for actin (Eaton,
1976; Cassell and Tobacman, 1996; Lehrer and Geeves,
1998). In terms of the Geeves and Lehrer model for thin
filament regulation, the binding of myosin heads (myosin
S1 or myosin S1-ADP) to actin shifts the equilibrium of
FIGURE 1 Ribbon diagram of the structure of the N-terminus of tropo-
myosin in a model peptide with the site of the Met8Arg mutation. The
model shows the coiled coil structure of TMZip, a synthetic peptide with
the first 14 residues of rat striated -TM and the last 18 residues of the
yeast GCN4 leucine zipper solved at atomic resolution using 2D-NMR
(Greenfield et al., 1998). The model is an average of the 15 best structures
from the NMR data. Residues 1–29 form a continuous coiled coil -helix,
while the last three residues (GlyGluArg) are disordered. The interface
position of the mutation is indicated. The model was prepared with MOL-
MOL (Koradi et al., 1996) using the coordinates deposited in the Protein
Data Bank (1TMZ, accession number 7983). The N-terminus is at the left.
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actin-TM from the closed state to the open state, in which
TM binds to actin with higher affinity and myosin binds
strongly and develops force (McKillop and Geeves, 1993;
reviewed in Lehrer, 1994; Lehrer and Geeves, 1998). We
have monitored myosin S1-induced binding of TM to actin
in the open state using a direct cosedimentation assay
(Eaton, 1976; Moraczewska et al., 1999). Myosin S1 in-
duced Met8Arg TM to bind to actin, but somewhat more
myosin S1 was consistently required for half-maximal bind-
ing (Fig. 3, Table 1). The difference reflects the weaker
actin affinity of Met8Arg TM, a major determinant of the
cooperativity of myosin S1 in inducing TM binding to actin
(Eaton, 1976; Moraczewska et al., 1999).
Regulation of the actomyosin S1
ATPase with troponin
Another measure of TM’s regulatory function is its ability
to regulate the actomyosin ATPase with Tn in a Ca2-
dependent fashion. Inhibition in the absence of Ca2 and
activation in the presence of Ca2 are analogs of relaxation
and contraction, respectively. Fig. 4 shows that Met8Arg
TM could inhibit the actomyosin S1 ATPase to the same
extent as wild-type TM, but there was little activation in the
presence of Ca2, even at much higher TM concentrations
(5 M) where Met8Arg TM would partially saturate the
thin filament (Fig. 2, Table 1). The lower activation in the
presence of Ca2 may indicate reduced effectiveness in
switching the thin filament to the open, force-producing
state related to reduced affinity or dissociation of TM. We
could not determine the actin affinity of Met8Arg TM for
actin in the conditions of the ATPase assay because Tn
binds non-specifically to actin at low ionic strength and may
carry TM with it (Hitchcock, 1975).
The Ca2-dependence of the regulated acto-myosin S1
ATPase was similar with wild-type and Met8Arg TM (Fig.
5). Although the cooperativity with Met8Arg TM may be
slightly greater than with wild type, the Ca2-dependence
was the same. The main difference, as in Fig. 4, was the
reduced activation in the presence of Ca2. In contrast,
Michele et al. (1999a) reported a slightly lower Ca2 sen-
sitivity of steady-state isometric force of adult cardiac myo-
cytes expressing Met8Arg TM compared to wild type. As
our steady-state ATPases are in solution, the conditions
would relate, at best, to unloaded shortening velocity in an
intact muscle.
The functional assays all required different ionic condi-
tions, for practical reasons. The myosin-S1 induced binding
was assayed in conditions where TM alone binds poorly to
actin. The higher ionic strength (150 mM NaCl) used to
measure actin affinity was chosen to optimize TM binding
FIGURE 2 Binding of wild-type (F) and M8R tropomyosin (f) to actin
in the presence of Tn, Ca2 (A) and Tn, 
Ca2 (B). Tropomyosin at
increasing concentrations was cosedimented with 5 M actin in 150 mM
NaCl, 10 mM Tris-HCl, pH 7.5, 2 mM MgCl2, 0.5 mM DTT, 0.1 mM
CaCl2 or 0.2 mM EGTA, as described in Materials and Methods. The
troponin concentration was at 1.2 molar excess over TM. The TM binding
curves were fit to the data using the Hill equation (Table 1).
FIGURE 3 Myosin S1-induced binding of wild-type tropomyosin (F)
and M8RTM (f) to actin. Binding of TM (1 M) and S1 to actin (3 M)
was measured as a function of S1 concentration (0–4.2 M) in 30 mM
NaCl, 0.5 mMMgCl2, 1 mM DTT, 10 mM imidazole, pH 7.0, as described
in Materials and Methods. The TM binding curves were fit to the data from
three experiments using the Hill equation (Table 1). The dashed line shows
myosin S1 binding to actin, fit by linear regression to the experimental
points for the S1/actin ratios from 0–1.0. The line at saturation was drawn
manually.
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while minimizing actin binding of Tn alone to actin (Hitch-
cock, 1975). The ATPases were at lower ionic strength to
allow higher acto-myosin S1 ATPase, while the high Mg2
concentration promotes actin binding. The TM affinity
would be expected to be at least as high as that in the
cosedimentation experiment.
Michele et al. (1999a) have expressed Met8Arg TM in
cultured adult cardiac myocytes using adenoviral-mediated
gene transfer. The mutant TM is incorporated into the
myofibrils and the myocytes are capable of normal force
generation with reduced Ca2 sensitivity. It is difficult to
compare their results to ours for several reasons. Most
important is that their recombinant TMs carry an eight-
residue, highly charged acidic FLAG epitope on the C-
terminus to allow localization using immunocytochemistry.
The effect of the epitope on TM function has not been
investigated in vitro, but it is attached to a functionally
critical end of TM known to bind to Tn (Hammell and
Hitchcock-DeGregori, 1996, 1997). A mutation resulting in
a C-terminal extension results in nemaline myopathy
(Beggs, personal communication). Also, the C-terminal
nine amino acids overlap with the highly conserved first
nine amino acids at the N-terminus to form a complex that
is critical for actin binding and regulatory function, and is
the site of the Met8Arg mutation. The expressed FLAG-
TMs (mutant or wild-type) are not incorporated along the
full I band in myocytes used for force measurements after
5–6 days in culture (Michele et al., 1999a, b). The published
gels show that the FLAG-TMs may be selectively extracted
upon cell permeabilization; wild-type FLAG-TM does not
seem to replace the endogenous TM. The endogenous TM is
TABLE 1 Binding of wild-type and mutant TM to actin in the presence of Tn or myosin S1
TM-actin binding constant Kapp (M

1)
S1/actin molar ratio*
Number of S1 per 7
actin subunits*Tn,  Ca2 Tn, 
 Ca2
wt TM 8.2  0.22  106 108 0.38  0.08 2.7  0.5
M8R TM 3  105 3.1  0.10  106 0.47  0.07 3.3  0.5
*Myosin S1/actin ratio for half-maximal saturation of F-actin with TM  SE (n  3). The values are statistically different (p  0.005, paired t-test).
FIGURE 4 Acto-myosin S1 ATPase regulation by wild-type (circles)
and M8R tropomyosin (squares). Actin (5 M), S1 (1 M), Tn (1 M),
and tropomyosin (0–1 M) were incubated at 28°C in 5 mM imidazole, pH
7.0, 40 mM NaCl, 5 mM MgCl2, 0.5 mM DTT, and either 0.1 mM CaCl2
(closed symbols) or 0.2 mM EGTA (open symbols). The triangle indicates
ATPase activity of myosin S1 alone.
FIGURE 5 Calcium dependence of the acto-myosin S1 ATPase. The
conditions are as for Fig. 4 except wild-type TM was 0.8 M (F) and
Met8Arg TM was 5 M (f) and with 0.45 mM CaEGTA. The free Ca2
concentration was controlled using CaEGTA buffer (see Materials and
Methods). (A) A representative experiment showing specific activity (nmol
Pi/nmol S1/s). (B) Normalized data from three (wt TM) or two (Met8Arg
TM) independent experiments. Each set of data was normalized individu-
ally to its own maximal activity. The points are averages (SE) of
normalized data. The Ca2 concentration for half-maximal ATPase acti-
vation was the same for both TMs (p  0.95, t-test): 3.98  0.19  10
7
(n  3) for wild-type TM, and 4.03  0.68  10
7 for Met8Arg TM (n 
2). The Hill coefficient was 1.79  0.16 (n  3) for wild-type TM and
2.96  0.26 (n  2) for Met8Arg TM. These values are marginally
different (p  0.07, t-test).
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not down-regulated unless the myocytes redifferentiate
(Michele et al., 1999b).
Local destabilization of TM by Met8Arg
Conformational analysis of Met8Arg TM using circular
dichroism showed that the effect of the mutation on the TM
conformation is local and that it did not affect the overall
folding and conformation of TM (Fig. 6 A). The mutation
caused a decrease in TM of 	0.6°C (TM of wild-type TM 
42.9  0.5°C, n  6; Met8Arg TM  42.3  0.2°C, n 
3; 1.5 M TM). There was also a small change in the mean
residue ellipticity of the fully folded proteins at 0°C, but the
difference was within the experimental error of the deter-
mination of the protein concentration. The lack of effect
would be anticipated since TM is a linear molecule and the
mutation represents only one residue out of 284.
Although the Met8Arg mutation had little effect on the
overall stability of TM, its location at an a interface position
of the coiled-coil heptapeptide repeat predicts a local desta-
bilization effect (Greenfield and Hitchcock-DeGregori,
1995). To test this idea, we introduced the mutation into a
model peptide, TMZip, whose structure had been deter-
mined using 2D-NMR (Greenfield et al., 1998). TMZip
consists of the first 14 N-terminal residues of rat striated
-TM and the last C-terminal 18 residues of the GCN4
leucine zipper (Landschulz et al., 1988; O’Shea et al., 1991)
to allow formation of a stable two-chained coiled coil. The
N-terminal Met is acetylated. TMZip forms a continuous
coiled coil -helix from residues 1–29; the C-terminus
(GlyGluArg) is disordered in TMZip as well as in the parent
GCN4 peptide (O’Shea et al., 1991; Greenfield et al., 1998).
Fig. 1 illustrates the interface position of the Met8Arg
mutation in the structure.
The folding properties of TMZip and Met8Arg TMZip
were also compared using CD spectroscopy. The mutation
profoundly decreased the stability of TMZip. At 150 M,
the apparent TM folding was decreased from 36°C to 	1°C
(Fig. 6 B, Table 2). To better estimate the mean residue
ellipticity of the Met8Arg peptide, and the value of TM at
K  1, CD data were collected over a wide concentration
range and were globally fit to the Gibbs-Helmholtz equation
for the unfolding of a two-stranded dimer to monomer. The
mutation decreased the enthalpy of unfolding from 38.5 to
22.6 Kcal/mol, and the mean residue ellipticity at 222 nm
decreased from 
27,800 to 
15,900 deg  cm2/dmol, al-
though the extrapolated TM value of folding at K  1 was
almost unchanged. The results show that the mutation
greatly destabilizes the folding of TMZip, although it can
still partially fold to form a coiled coil at very low temper-
atures. The folding is probably mainly due to the C-termi-
nal, GCN4 portion of the peptide. The stability of
Met8ArgTMZip is similar to that of a 24-residue GCN4
peptide corresponding to the C-terminal portion of TMZip
(Lumb et al., 1994). We suggest that the decrease in the
enthalpy and loss of ellipticity are caused by the loss of
approximately four helical turns of coiled coil (13–16 res-
idues) that correspond to the N-terminal TM portion of the
peptide.
The recombinant TM expressed in E. coli is unacetylated.
We have shown that N-acetylation stabilizes the coiled coil
conformation of an N-terminal peptide (Greenfield et al.,
1994) and increases actin affinity of striated -TM (Urban-
cikova and Hitchcock-DeGregori, 1994). The results here
with the peptides show that the mutation is deleterious to the
TM structure even when the N-terminal Met is acetylated.
Competition experiments
In TPM3 the Met8Arg mutation exhibits autosomal domi-
nant inheritance (Laing et al., 1995). Tropomyosin is a
two-chained coiled coil and in heterozygotes half of the
FIGURE 6 Effect of the nemaline myopathy mutation on the folding of
a tropomyosin and a tropomyosin model peptide. (A) Circular dichroism of
wild-type TM (F) and Met8ArgTM (f). Mean residue ellipticity at 222 nm
as a function of temperature in 500 mM NaCl, 1 mM EDTA, 1 mM DTT,
10 mM sodium phosphate, pH 7.5, 1.5 M protein. (B) Circular dichroism
of TMZip and M8R TMZip. Mean residue ellipticity at 222 nm as a
function of temperature in 100 mM NaCl, 10 mM NaPO4, pH 6.9. TMZip
(F) and M8RTMZip (f) were 1.1 mg/ml (150 M).
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expressed -TM molecules should have one normal chain
and one mutant chain, given the similar stabilities in vitro of
the full-length wild-type and mutant TMs. -Tropomyosin
could also form heterodimers with the products of other TM
genes. Since the mutation has only a local effect on the
stability of the TM coiled coil, mutant TM could be domi-
nant by negatively influencing N-terminal-associated func-
tions of the wild-type TM chain in heterodimers: actin
affinity, head-to-tail association of neighboring TM mole-
cules on the actin filament, binding to tropomodulin, and
interaction with Tn at TM’s molecular ends. The mutation
could also have a dominant effect in homodimers by coop-
eratively influencing the functions of neighboring TM mol-
ecules, such as end-to-end association. To address the latter
question, we compared the actin binding (with Tn, Ca2)
of wild-type-Met8Arg TM mixtures to the binding of the
two forms alone over a concentration range where wild-type
TM binds well and Met8Arg TM binds poorly. The binding
of the mixed samples was indistinguishable from the bind-
ing of the sum of the two forms alone (results not shown).
The failure of Met8Arg homodimers to compete with wild
type may reflect its low affinity and the absence of end-to-
end association in solution (versus on the filament) in the
conditions of our experiment. We obtained similar negative
results in previous mixing experiments with TMs carrying
N-terminal modifications (Heald and Hitchcock-DeGregori,
1988). We could not evaluate the function of heterodimers.
Since two TMs comigrate in SDS-PAGE and in urea gels,
we were unable to confirm the presence of heterodimers in
unfolded and refolded mixtures of wild-type and mutant
TM. Michele et al. (1999a) did not address the question of
whether the FLAG-TMs form heterodimers with endoge-
nous TM.
CONCLUSIONS
The effect of the nemaline myopathy-causing mutation in
TM, Met8Arg, is consistent with the mutation affecting thin
filament and sarcomere assembly, and cooperative func-
tions within the thin filament, rather than affecting the
ability of TM to form a stable coiled coil. Our in vitro
experiments suggest that if Met8Arg TM can assemble into
a regulated actin filament it can function quite normally.
When bound, the extent of inhibition of the regulated acto-
myosin S1 ATPase by Met8Arg TM in the absence of Ca2
and the Ca2-dependence of the acto-myosin S1 ATPase
are normal. The mutation impairs myosin S1-induced TM
binding as well as activation of the acto-myosin S1 ATPase
in the presence of Ca2. These results imply that the mu-
tation impairs the switch of the thin filament to the full
open, force-producing state and may cause associated mus-
cle weakness. However, the main effect of the mutation is
the weaker actin affinity. Impaired end-to-end interactions
of the TMs along the length of the thin filament may make
thin filament assembly more difficult and result in less
stable actin filaments. The N-terminus of TM is oriented
toward the “pointed” or “minus” end of the thin filament,
away from the Z-line, where the thin filament is capped by
tropomodulin (Weber et al., 1994, 1999; Fowler et al.,
1993). The Met8Arg mutation may alter the dynamics of the
actin filament during initial assembly and in the mature
myofibril. Failure of tropomodulin to properly cap thin
filaments may result in long filaments that prevent normal
sarcomere assembly. Weakened TM binding may allow
these filaments to be cross-linked by -actinin. It would be
valuable to obtain information on the myofibrillar organi-
zation and the levels of expression and localization of
Met8Arg TM in the muscles of individuals harboring the
mutation.
Neither our study, nor that of Michele et al. (1999a) can
yet address the mechanism of dominant inheritance of the
Met8Arg mutation. We would anticipate that the mutated
protein is expressed and that it is dominant because it can
form a coiled coil TM with wild-type striated muscle -TM
or another isoform. The mutation would likely destabilize
the N-terminal overlap region in homodimers or het-
erodimers and result in altered end-to-end association and
Tn binding on the actin filament. Met-8 is conserved
throughout phylogeny in 284-residue TMs, and is fre-
quently found at the interface a position in the heptapeptide
repeat of the coiled coil. In contrast, Arg is rare at this
position, being absent from any a position in most TMs.
One may deduce that it would impair the stability of the
coiled coil, especially at the end of the molecule, whether in
a homodimer or heterodimer.
TABLE 2 Effect of the Met8Arg mutation on the thermodynamics of folding of a chimeric N-terminal peptide, TMZip
Peptide
Max  10
3
deg  cm2  dmol
1
Min  10
3
deg  cm2  dmol
1
Hunfolding
Kcal/mol
TM(apparent), °C
150 M
TM, °C
K  1, G  0
TMZip 
27.8  0.1 
6.2  0.1 38.5  0.2 36.1  0.1 82.0  0.4
M8R TMZip 
15.9  0.1 
6.6  0.1 22.6  0.3 1.3  0.3 84.0  0.9
The sequence of TMZip (Greenfield et al., 1998) is: Ac-MDAIKKK (M/R)QMLKLD NYHLENE VARLKKL VGER where the first 14 residues are from
TM and the last 18 are from the GCN4 leucine zipper (Landschulz et al., 1988). In -TM residue 2 is Glu instead of Asp. Circular dichroism data were
collected from 0 to 60°C in 100 mM NaCl, 10 mM sodium phosphate pH 6.9 at 222 nm. The concentrations of TMZip were 1.5, 7.7, 15, and 150 M,
and of Met8Arg TMZip were 15, 38, 150, and 224 M. Data were fit globally ( SE) to a two-state transition between a folded dimer and an unfolded
monomer as described in Greenfield et al. (1998).
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The relatively mild progression of the disease is likely
because TPM3 is expressed only in type 1, slow fibers, and
it is not the only TM expressed in many slow fibers.
Furthermore, -TM muscle TM is the only long isoform
expressed by TPM3. Were the comparable mutation to
occur at Met-8 in the genes encoding  or -TMs that
encode the major muscle TM isoforms as well as TMs
expressed in most non-muscle cells, the effects would likely
be dominant and lethal.
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